VPPRN Patient-Powered Research
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Every 6 months, we ask our VPPRN community to check-in and tell us how they are doing. The graphs below reflect the scores/ratings of patients with eosinophilic granulomatosis with polyangiitis (EGPA) compared to the Network as a whole. Here is what we learned about flares, fatigue, pain, symptoms of vasculitis, and members’ current state of vasculitis at the January 2026 check-in:
- Compared to patients with other forms of vasculitis, patients with EGPA reported the following:
- similar percentage of flares reported
- similar scores for fatigue
- higher scores/ratings for their symptoms of vasculitis over the past 28 days
- similar scores for pain
- a similar percentage of patients with EGPA reported their vasculitis as currently active.
- Compared to patients with other forms of vasculitis, patients with EGPA reported the following:
If you have concerns about your health scores, please discuss with your rheumatologist or primary care provider.
- Not a member? Click JOIN THE VPPRN button below.
- Already a VPPRN Member? Use the LOGIN button to access your account.
FLARES and VASCULITIS
Flare Reporting: Patients with EGPA reported flare rates similar to those seen across the VPPRN community. At the January 2026 check-in, 67% of patients with EGPA reported no flares in the past 6 months, compared with 72% of participants across the overall Network.
Patients with EGPA
Entire VPPRN Community
FATIGUE and VASCULITIS
Fatigue: Fatigue was common among patients with EGPA, with rates similar to the broader VPPRN community. At the January 2026 check-in, 85% reported experiencing fatigue in the past 7 days, compared with 87% across the Network.
Patients with EGPA
Entire VPPRN Community
SYMPTOMS of VASCULITIS
Symptoms of Vasculitis: Compared with the overall VPPRN community, patients with EGPA reported more vasculitis symptoms. At the January 2026 check-in, 15% of patients with EGPA reported no symptoms over the past 28 days, compared with 23% of participants across the Network.
Patients with EGPA
Entire VPPRN Community
PAIN and VASCULITIS
Pain: Patients with EGPA reported pain levels similar to those seen across the VPPRN community. At the January 2026 check-in, 81% of patients with EGPA reported no to moderate pain (scores 0–5), compared with 83% of participants across the Network.
Patients with EGPA
Entire VPPRN Community
MEMBERS' CURRENT STATE OF VASCULITIS
Members’ Current State of Vasculitis: Patients with EGPA reported active disease at rates similar to the overall VPPRN community. At the January 2026 check-in, 23% reported their vasculitis as active, compared with 21% of participants across the Network.
Patients with EGPA
Entire VPPRN Community
